Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

InfuSystem Holdings (INFU) Long-Term Debt Issuances (2012 - 2018)

InfuSystem Holdings posted quarterly Long-Term Debt Issuances of $1.5 million for Q4 2018, up 173.59% year-on-year from $549000.0 in Q4 2017, and up 173.59% on a QoQ basis from $549000.0 in Q4 2017.

InfuSystem Holdings (INFU) has 3 years of Long-Term Debt Issuances data on file, last reported at $1.5 million in Q4 2018.

  • For the quarter ending Q4 2018, Long-Term Debt Issuances rose 173.59% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2018 stood at $26.3 million (down 9.0% YoY), and the FY2021 full-year result was $76.2 million, up 102.71% from the prior year.
  • Long-Term Debt Issuances for Q4 2018 stood at $1.5 million, up from $549000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $15.0 million in Q2 2017 and bottomed at $549000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 InfuSystem Holdings 200.09 Mn 197.98 Mn 19.68 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 1.50 Mn
Dec 31, 2018 1.50 Mn
Dec 31, 2017 549,000.00
Dec 31, 2017 549,000.00
Sep 30, 2017 9.21 Mn
Sep 30, 2017 9.21 Mn
Jun 30, 2017 15.01 Mn
Jun 30, 2017 15.01 Mn
Mar 31, 2017 4.10 Mn
Mar 31, 2017 4.10 Mn
Mar 31, 2012 2.50 Mn
Mar 31, 2012 2.50 Mn